A Win For Veru Inc.
Thu, Feb 04, 2021 at 05:30 PM
Veru Inc. (VERU:NASDAQ) soared at $14.28, representing a gain of 44.4%. On Wed 03 Feb 21, VERU:NASDAQ hit a New 2-Week High of $9.89. The stock appeared on our News Catalysts scanner on Wed 03 Feb 21 at 01:44 PM in the 'EARNINGS' category. From Wed 20 Jan 21, the stock recorded 50.00% Up Days and 63.64% Green Days
The stock spiked on Tue 15 Dec 20 at $11.45 with a volume of 65M+, and its share price has been moving sideways in recent weeks.
About Veru Inc. (VERU:NASDAQ)
Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility and novel chemotherapies for a variety of cancers.
Top 10 Gainers:
- ATA Creativity Global (AACG:NASDAQ), 936.23%
- Lizhi Inc. (LIZI:NASDAQ), 70.47%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 68.27%
- CYTH (CYTH:NASDAQ), 59.39%
- Midatech Pharma plc (MTP:NASDAQ), 47.29%
- Veru Inc. (VERU:NASDAQ), 44.39%
- Meten EdtechX Education Group Ltd. (METX:NASDAQ), 44.21%
- Anavex Life Sciences Corp. (AVXL:NASDAQ), 43.64%
- DAVIDsTEA Inc. (DTEA:NASDAQ), 42.24%
- SANA (SANA:NYSE), 40.4%